Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of BRV-PV (Rotasiil) in Indian Infants
NCT02133690Phase 3Completed
- Sponsor
- Serum Institute of India
- Start
- May 2014
- Primary completion
- Mar 2016
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Rotasil in rotavirus gastroenteritis, sponsored by Serum Institute of India. Started May 2014; status: completed.
02
Drugs
Rotasil
03
Conditions
rotavirus gastroenteritis
Beyond the preview
Go deeper on NCT02133690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02133690.